Richard Mazurchuk Selected Research

Richard Mazurchuk Research Topics

Disease

15	Neoplasms (Cancer) 01/2020 - 05/2002
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2006 - 12/2004
2	Squamous Cell Carcinoma of Head and Neck 07/2006 - 12/2004
2	Carcinoma (Carcinomatosis) 07/2006 - 01/2005
2	Brain Neoplasms (Brain Tumor) 03/2004 - 05/2002
1	Carcinogenesis 01/2018
1	Necrosis 05/2008
1	Pyruvate Dehydrogenase Complex Deficiency Disease 04/2007
1	Colonic Neoplasms (Colon Cancer) 02/2007
1	Hemorrhage 02/2007
1	Head and Neck Neoplasms (Head and Neck Cancer) 07/2006
1	Fibrosarcoma 01/2005
1	Phototoxic Dermatitis (Phototoxicity) 01/2005
1	Hypoxia (Hypoxemia) 12/2004
1	Neoplasm Metastasis (Metastasis) 05/2003
1	Gliosarcoma 05/2002

Drug/Important Bio-Agent (IBA)

5	1-phenyl-3,3-dimethyltriazene (PDT)IBA 05/2010 - 01/2005
4	2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH)IBA 05/2010 - 01/2005
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2012 - 05/2002
3	pyropheophorbide aIBA 05/2010 - 01/2005
3	Photosensitizing Agents (Photosensitizers)IBA 05/2010 - 06/2005
3	Pharmaceutical PreparationsIBA 05/2008 - 03/2004
3	vadimezanIBA 02/2007 - 06/2005
2	Biological ProductsIBA 01/2018 - 01/2018
2	Pentetic Acid (DTPA)FDA LinkGeneric 05/2010 - 01/2005
2	AcidsIBA 05/2010 - 06/2005
2	Contrast MediaIBA 02/2007 - 06/2005
2	Fluorouracil (Carac)FDA LinkGeneric 12/2004 - 05/2003
2	Liposomes (Liposome)IBA 03/2004 - 05/2002
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	CarcinogensIBA 01/2018
1	liposomal doxorubicin (Doxil)FDA Link 12/2012
1	Angiogenesis InhibitorsIBA 12/2012
1	cadherin 5IBA 12/2012
1	diethylenetriamineIBA 05/2010
1	GadoliniumIBA 05/2010
1	Chlorophyll AIBA 05/2010
1	Oxygen (Dioxygen)IBA 05/2008
1	Evans Blue (Blue, Evans)FDA Link 05/2008
1	Protons (Proton)IBA 04/2007
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 02/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2007
1	AT 112IBA 06/2005
1	methyl cellosolve (ethylene glycol monomethyl ether)IBA 01/2005
1	Ether (Diethyl Ether)IBA 01/2005
1	Carbonic Anhydrase IXIBA 12/2004
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2004
1	pimonidazoleIBA 12/2004
1	involucrinIBA 12/2004
1	Differentiation AntigensIBA 12/2004
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2004
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2004
1	Drug CarriersIBA 03/2004
1	CytosineIBA 05/2003
1	sapacitabineIBA 05/2003
1	Gemcitabine FDA Link 05/2003

Therapy/Procedure

6	Therapeutics 01/2020 - 03/2004
3	Photochemotherapy (Photodynamic Therapy) 05/2010 - 06/2005
3	Aftercare (After-Treatment) 02/2007 - 06/2005
2	Drug Therapy (Chemotherapy) 01/2005 - 12/2004
1	Immunotherapy 01/2020
1	Phototherapy (Light Therapy) 05/2010
1	Lasers (Laser) 05/2008
1	Combination Drug Therapy (Combination Chemotherapy) 12/2004